US 9272137
Transdermal methods and systems for the delivery of anti-migraine compounds
granted A61KA61K31/4045A61K9/7038
Quick answer
US patent 9272137 (Transdermal methods and systems for the delivery of anti-migraine compounds) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4045, A61K9/7038, A61P, A61P25/06